Overview
CO2Lift creates skincare products that use transdermal carboxytherapy to deliver carbon dioxide to the skin. Its two-part gel releases CO2 when mixed, triggering a Bohr-effect increase in blood flow and oxygen to the treated area, which improves hydration, collagen production, and tissue regeneration for firmer, brighter skin with less downtime. The company sells at-home kits for consumers and medical-grade versions for professionals (CO2Lift PRO), plus CO2LiftV for intimate wellness, combining consumer and post-procedure support in one portfolio. Its exclusive Japanese topical CO2 gel patent and dual-channel approach set it apart, with a goal of non-invasive skin rejuvenation and faster healing after procedures.
Work here?Claim your company
Simplify's take
What believers are saying
- August 2026 GLO debuted at Cosmoprof North America, expanding consumer reach.
- September 2026 and November 2026 events elevated CO2Lift alongside women’s health longevity trends.
- Provider listings updated October 2026 show active distribution across U.S. and Europe.
What critics are saying
- 2026 marketing still leans on press releases, not independent clinical adoption proof.
- FDA disclaimer language signals cosmetic positioning; any medical claims invite regulatory scrutiny.
- Founder-centric brand risk is extreme: Lana Kerr drives product, media, and strategy.
What makes CO2Lift unique
- CO2Lift is one of few topical carboxytherapy brands selling both professional and consumer lines.
- Lana Kerr is pushing HERgevity, linking skin, intimate wellness, and women’s longevity.
- CO2Lift’s 2026 portfolio spans PRO, GLO, and CO2LiftV, broadening use cases.
Help us improve and share your feedback! Did you find this helpful?